Minimizing Risks, Maximizing Speed: Streamlining Your Supply Chain from Research to Rollout
Wednesday, May 29, 2024 10:45 AM - 11:45 AM
Room 205-207
Bioprocessing & Manufacturing, RoundtableOrganized by Bio IVT
Moderator:
- Courtney Noah, PhD, VP, Scientific Affairs, BioIVT, USA
Panelists:
- Kevin King, Senior Director, Donor Center Strategy and Growth, BioIVT, United States
- Tim Largen, BS, MBA, Chief Operating Officer, Applied StemCell
- Lee Buckler, Senior VP of Advanced Therapies, Blood Centers of America, United States
Learning Objectives:
1. Identify the key risks that impact supply chain and manufacturing processes.
2. The essential components of a robust regulatory and manufacturing framework.
3. Identify key attributes for HCT/Ps and ancillary source material providers.
4. CELLARES: Elevating Cell Therapy Manufacturing Using Industry 4.0: Unlocking Total Patient Access for Life-Saving Therapies
SPONSORED BY:
